- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-tetramer
- Ligands
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x CA: CALCIUM ION(Non-covalent)
- 4 x G39: (3R,4R,5S)-4-(acetylamino)-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid(Non-covalent)
G39.4: 15 residues within 4Å:- Chain A: R.36, E.37, D.69, R.70, W.97, I.141, R.143, S.165, E.195, E.196, R.211, N.213, R.286, Y.320
- Ligands: EPE.5
12 PLIP interactions:12 interactions with chain A- Hydrophobic interactions: A:W.97, A:I.141, A:I.141
- Hydrogen bonds: A:E.37, A:R.70, A:Y.320
- Water bridges: A:D.69, A:R.70, A:E.196
- Salt bridges: A:R.36, A:R.211, A:R.286
G39.10: 14 residues within 4Å:- Chain B: R.36, E.37, D.69, R.70, W.97, R.143, S.165, E.195, E.196, R.211, N.213, R.286, Y.320
- Ligands: EPE.11
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:W.97, B:E.195
- Hydrogen bonds: B:E.37, B:R.70
- Water bridges: B:D.69, B:R.74, B:E.196
- Salt bridges: B:R.36, B:R.211, B:R.286
G39.17: 15 residues within 4Å:- Chain C: R.36, E.37, D.69, R.70, W.97, I.141, R.143, S.165, E.195, E.196, R.211, N.213, R.286, Y.320
- Ligands: EPE.18
14 PLIP interactions:14 interactions with chain C- Hydrophobic interactions: C:W.97, C:I.141, C:E.195, C:N.213
- Hydrogen bonds: C:E.37, C:R.70, C:Y.320
- Water bridges: C:D.69, C:R.74, C:E.196, C:R.211
- Salt bridges: C:R.36, C:R.211, C:R.286
G39.25: 14 residues within 4Å:- Chain D: R.36, E.37, D.69, R.70, W.97, R.143, S.165, E.195, E.196, R.211, N.213, R.286, Y.320
- Ligands: EPE.26
12 PLIP interactions:12 interactions with chain D- Hydrophobic interactions: D:W.97
- Hydrogen bonds: D:E.37, D:R.70, D:Y.320
- Water bridges: D:D.69, D:D.69, D:R.74, D:E.196, D:E.196
- Salt bridges: D:R.36, D:R.211, D:R.286
- 4 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
EPE.5: 6 residues within 4Å:- Chain A: I.67, K.68, D.69, R.286, P.349
- Ligands: G39.4
8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:D.69, A:D.69
- Water bridges: A:R.70, A:R.70, A:R.286, A:R.286, A:K.350
- Salt bridges: A:D.69
EPE.11: 6 residues within 4Å:- Chain B: I.67, K.68, D.69, R.286, P.349
- Ligands: G39.10
8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:D.69, B:D.69, B:D.69
- Water bridges: B:R.70, B:R.70, B:R.286
- Salt bridges: B:D.69, B:D.69
EPE.18: 6 residues within 4Å:- Chain C: I.67, K.68, D.69, R.286, P.349
- Ligands: G39.17
8 PLIP interactions:8 interactions with chain C- Hydrogen bonds: C:D.69, C:D.69, C:D.69
- Water bridges: C:R.70, C:R.70, C:R.286, C:R.286
- Salt bridges: C:D.69
EPE.26: 6 residues within 4Å:- Chain D: I.67, K.68, D.69, R.286, P.349
- Ligands: G39.25
7 PLIP interactions:7 interactions with chain D- Hydrogen bonds: D:D.69, D:D.69
- Water bridges: D:R.70, D:R.70, D:R.286, D:K.350
- Salt bridges: D:D.69
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.6: 1 residues within 4Å:- Chain A: N.6
No protein-ligand interaction detected (PLIP)NAG.7: 3 residues within 4Å:- Chain A: K.2, N.153, Q.226
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:K.2, A:N.153, A:Q.226
NAG.12: 2 residues within 4Å:- Chain B: N.6, S.7
No protein-ligand interaction detected (PLIP)NAG.13: 4 residues within 4Å:- Chain B: K.61, N.64, I.354, I.385
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:I.354
- Hydrogen bonds: B:N.64
NAG.14: 2 residues within 4Å:- Chain B: K.2, N.153
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:K.2
NAG.19: 1 residues within 4Å:- Chain C: N.6
No protein-ligand interaction detected (PLIP)NAG.20: 3 residues within 4Å:- Chain C: N.64, I.354, I.385
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:I.354
- Hydrogen bonds: C:N.64
NAG.21: 2 residues within 4Å:- Chain C: K.2, N.153
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.153
NAG.22: 2 residues within 4Å:- Chain C: D.302, N.304
No protein-ligand interaction detected (PLIP)NAG.27: 1 residues within 4Å:- Chain D: N.6
No protein-ligand interaction detected (PLIP)NAG.28: 3 residues within 4Å:- Chain D: N.64, I.354, I.385
2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:I.354
- Hydrogen bonds: D:N.64
NAG.29: 2 residues within 4Å:- Chain D: K.2, N.153
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:N.153
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Van Der Vries, E. et al., H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis. Plos Pathog. (2012)
- Release Date
- 2012-10-03
- Peptides
- NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-tetramer
- Ligands
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x CA: CALCIUM ION(Non-covalent)
- 4 x G39: (3R,4R,5S)-4-(acetylamino)-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid(Non-covalent)
- 4 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Van Der Vries, E. et al., H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis. Plos Pathog. (2012)
- Release Date
- 2012-10-03
- Peptides
- NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D